top of page
Search

Moderna’s coronavirus vaccine found to be nearly 95% effective in a preliminary analysis

Biotechnology firm Moderna announced that a preliminary analysis shows its experimental coronavirus vaccine is nearly 95% effective at preventing illness, including severe cases — a striking initial result that raises the prospect that the US could have two coronavirus vaccines available on a limited basis by the end of the year.


The news comes a week after pharmaceutical giant Pfizer and its German partner BioNTech lifted people’s hopes with the news that their coronavirus vaccine was more than 90 percent effective.




 
 
 

Comments


Subscribe Form

Thanks for submitting!

©2020 by Mostly Microbes and Infectious Diseases. Proudly created with Wix.com

bottom of page